Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| pt-A | ptAW52 | U.S. | 1996 | HIV1 | B | PBMC | MMC |
Treatment History
| Order | Regimen | Weeks |
| 1 | IDV | 52 |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| M46I, I54V, V82T | L24I, G73S | L10R, K20I, R57K, L63P, A71V |
| >ptAW52| 8 | codons 1-99 | clone 8 PQITLWQRPRVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKIIGGIGGFIRVKQYD QIPIEICGHKAIGTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW52| 7 | codons 1-99 | clone 7 PQITLWQRPRVTIKIGGQLIEALIDTGADDTVLEEMNLPGRWKPKIIGGIGGFVRVKQYD QIPIEICGHKIIGTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW52| 6 | codons 1-99 | clone 6 PQITLWQRPRVTIKIGGQLIEALIDTGADDTVLEEMNLPGRWKPKIIGGIGGFVKVRQYD QIPIEICGHKVISTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW52| 4 | codons 1-99 | clone 4 PQITLWQRPRVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKAIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW52| 3 | codons 1-99 | clone 3 PQITLWQRPVVTIKIGGQLIEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFVKVRQYD QIPIEICGHKVISTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW52| 2 | codons 1-99 | clone 2 PQITLWQRPRVTIKIGGQLIEALIDTGADDTVLEEMNLPGRWKPKIIGGIGGFVRVRQYD QIPIEICGHKAIGTVLVGPTPTNIIGRNLLTQIGRTLNF >ptAW52| 1 | codons 1-99 | clone 1 PQITLWQRPRVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKIIGGIGGFVRVRQYD QIPIEICGHKAIGTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW52| codons 1-99 PQITLWQRPRVTIKIGGQLIEALIDTGADDTVLEEMNLPGRWKPKIIGGIGGFVKVKQYD QIPIEICGHKVISTVLVGPTPTNIIGRNLLTQIGCTLNF |
References
| Author | Title | Citation |
| Condra, JH | Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. | J Virol, 1996 |
| Wu, TD | Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. | J Virol, 2003 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |